Hypertension Outcomes for T4 REsearch within Lower Middle-Income Countries (Hy-TREC) (U01)

The summary for the Hypertension Outcomes for T4 REsearch within Lower Middle-Income Countries (Hy-TREC) (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Hypertension Outcomes for T4 REsearch within Lower Middle-Income Countries (Hy-TREC) (U01): The purpose of this FOA is to support research that identifies and studies regional- or national-level implementation strategies for evidence-based interventions for the prevention, treatment, and control of hypertension in adults in World Bank defined Lower-MICs. The FOA will support research that tests evidence-based implementation strategies that can accelerate regional and national scale-up of hypertension interventions and support high priority locally-driven late-stage (T4) implementation research.
Federal Grant Title: Hypertension Outcomes for T4 REsearch within Lower Middle-Income Countries (Hy-TREC) (U01)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-17-014
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.840
CFDA Descriptions: Information not provided
Current Application Deadline: November 8th, 2016
Original Application Deadline: November 8th, 2016
Posted Date: August 11th, 2016
Creation Date: August 11th, 2016
Archive Date: December 9th, 2016
Total Program Funding: $7,250,000
Maximum Federal Grant Award: $268,500
Minimum Federal Grant Award:
Expected Number of Awards: 5
Cost Sharing or Matching: No
Last Updated: August 12th, 2016
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); See FOA for Eligibility Details
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-014.html
Grant Announcement Contact
NIH OER Webmaster
[email protected]

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (PRECluDE) (U0...
More Grants from the National Institutes of Health
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...
Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...
Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com